A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patients

NCT00479076 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: aflibercept (AVE0005)
DRUG: S-1

Sponsor

Sanofi

Collaborators

[object Object]